Category Archives: ALS Treatment

The Herald News WARWICK, RI A Wish Come True is making its 17th annual Polar Plunge at Easton Beach in Newport a virtual event this year due to the COVID-19 pandemic. Instead of plunging into the ocean, A Wish Come True is asking plungers to dump a bucket of ice water on themselves and share a video of it on social media platforms like Facebook and Instagram with the hashtag #AWCTPolarPlunge. The event was inspired by the Ice Bucket Challenge made popular by former Boston College baseball player Peter Frates, who lost his battle with ALS in 2019 Continue reading →

Overview Amyotrophic lateral sclerosis (a-my-o-TROE-fik LAT-ur-ul skluh-ROE-sis), or ALS, is a progressive nervous system disease that affects nerve cells in the brain and spinal cord, causing loss of muscle control. ALS is often called Lou Gehrig's disease, after the baseball player who was diagnosed with it. Continue reading →

Above: Listen to anaudio version of this story. Everybody who knows Jimmy Judge knows that the only place you could find him on a Friday night in the fall is on the sidelines cheering for his 17-year-old son Jakie. Continue reading →

Ness Ziona-based biotech firm Kadimastem has shown encouraging results of Cohort B of its Phase 1/2a clinical trial for AstroRx, its Amyotrophic Lateral Sclerosis (ALS) treatment trial. The objective of this trial was to evaluate the safety of their treatment, with a secondary objective of the trial of estimating its preliminary efficacy. The treatment was developed by Kadimastem and contains functional, healthy astrocytes (nervous system support cells) derived from Human Embryonic Stem Cells (hESC) that aim to protect diseased motor neurons Continue reading →

NEW YORK, Dec. Continue reading →

The ALS Treatment Market research report helps the market players to execute phenomenal business techniques and therefore, it has featured driving contenders vital moves including acquisitions, business extension, mergers, joint efforts, adventures, limited time exercises, branding, and product dispatches. The SWOT analysis incorporates inner and outside variables, just as present and future capability of the market. Continue reading →

December 16, 2020 11:55 ET | Source: AB Science multilang-release AB SCIENCE WILL HOST A LIVE WEBCAST ON THURSDAY DECEMBER 17, 2020 ON MASITINIB RESULTS IN ALZHEIMERS DISEASE Paris, December 16, 2020, 6pm CET AB Science SA (NYSE Euronext FR0010557264 AB) will host a live webcast on December 17, 2020 with key opinion leaders to discuss recently reported results from the Phase 2B/3 masitinib trial in Alzheimers Disease. Continue reading →

December 16, 2020 15:46 ET | Source: Stephen Siller Tunnel To Towers Foundation photo-release Staten Island, NY, Dec. 16, 2020 (GLOBE NEWSWIRE) -- The Tunnel to Towers Foundation and The Home Depot Foundation today announced that they have teamed up to provide financial assistance to three of our nations veterans this holiday season. Continue reading →

JERSEY CITY, N.J., Dec. 14, 2020 /PRNewswire/ --Mitsubishi Tanabe Pharma America, Inc. Continue reading →

CAMBRIDGE, Mass.--(BUSINESS WIRE)--QurAlis Corporation, a biotech company focused on developing precision medicines for amyotrophic lateral sclerosis (ALS) and other neurologic diseases, today announced the results of extensive pre-clinical studies on its lead program, QRA-244, for ALS patients. QRA-244 is a Kv7.2/7.3 ion channel opener optimized for both safety and efficacy as a potential treatment for motor neuron hyperexcitability-induced neurodegeneration in ALS patients Continue reading →